Drugs@FDA document
TRIDIONE Letter · NDA 005856 SUPPL-21
Drugs@FDA document · ABBVIE · Jun 8, 2012
Key facts
| Drug name | TRIDIONE |
|---|---|
| Document type | Letter |
| Application | NDA005856 |
| Submission | SUPPL-21 |
| Company | ABBVIE |
| Document date | Jun 8, 2012 |
| FDA document | accessdata.fda.gov |
At a glance
- Labeling, REMS-Proposal Document categories
- 1–9 Documents for this application
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: